糖尿病足患者创面病原菌分布及耐药性变迁

doi:10.3969/j.issn.1000-8535.2018.05.020

广州医药 ›› 2018, Vol. 49 ›› Issue (5): 81-85.DOI: 10.3969/j.issn.1000-8535.2018.05.020

糖尿病足患者创面病原菌分布及耐药性变迁

刘思容, 荣新洲, 李庆辉

广州市第一人民医院(广州 510180)

收稿日期:2018-06-06 出版日期:2018-09-20 发布日期:2021-11-29

Change of pathogen distribution and drug resistance in patients with diabetic foot

LIU Sirong, RONG Xinzhou, LI Qinghui

Guangzhou First People's Hospital,Guangzhou 510180,China

Received:2018-06-06 Online:2018-09-20 Published:2021-11-29

摘要/Abstract

摘要： 目的了解广东地区糖尿病足患者创面病原菌分布及耐药性变迁。方法回顾性分析A组(2010年1月—2014年12月就诊的糖尿病足患者)和B组(2015年1月—2018年1月就诊的糖尿病足患者)研究者创面病原菌分布及耐药性变迁。结果 B组中创面G⁺菌及G^-菌均有下降趋势且G^-菌下降较快,细菌种类明显增加,真菌及混合感染明显上升,A组以金黄色葡萄球菌、铜绿假单胞菌、大肠埃希菌感染为主;B组以金黄色葡萄球菌、奇异变形杆菌、铜绿假单胞菌及真菌感染为主;B组相对于A组的细菌耐药性增加。结论近年来糖尿病足患者病原菌种类明显增加且混合感染及真菌感染上升,且其耐药性增加,因此早期经验用药而后根据药敏选择抗菌药物治疗是糖尿病足感染治疗的关键。

关键词: 糖尿病足, G⁺菌, G^-菌, 真菌, 耐药性

Abstract: Objective To investigate the distribution and drug resistance of pathogenic bacteria in diabetic foot wounds in Guangdong area. Methods Patients with diagnosis of diabetic foot between group A (from Jan 2010~Dec 2014 ) and group B (from Jan 2015 to Jan 2018) were retrospectively analyzed. We studied the bacteria distribution and drug resistance of pathogenic changes of group A and group B. Results In group B, both G+ and G- bacteria had a decreased trend while G- bacteria decreased rapidly, but the species of bacteria increased obviously just as fungi and mixed infection increased obviously. Bacteria infection in group A were mainly about Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli wihle group B were Staphylococcus aureus, Proteus mirabilis, Aeruginosa and Fungal infection; the resistance of group B to A was lower. Conclusion In recent years, kinds of pathogenic bacteria of diabetic foot were significantly increased and the mixed infection and increased fungal infection as well as its drug resistance increased, so the early experience of medication choice of antibiotics based on drug sensitivity and treatment are the key to the treatment of diabetic foot infection.

Key words: Diabetic Foot, G⁺ Bacteria, G^- bacteria, Fungi, Drug Resistance

刘思容, 荣新洲, 李庆辉. 糖尿病足患者创面病原菌分布及耐药性变迁[J]. 广州医药, 2018, 49(5): 81-85.

LIU Sirong, RONG Xinzhou, LI Qinghui. Change of pathogen distribution and drug resistance in patients with diabetic foot[J]. Guangzhou Medical Journal, 2018, 49(5): 81-85.

参考文献

[1] IMRAN S, ALI R, MAHBOOB G. Frequency of lower extremity amputation in diabetics with refer extremity amputation in diabetics with refer encetoglycemic control and Wagner's grades[J]. JCPSP-J Coll Physici,2006, 16(2): 124-127.
[2] 萧正华,陈定宇,刁学廉,等. 血浆免疫指标变化与糖尿病足部感染[J]. 广州医学院学报,2002,30(1):35-37.
[3] SINGH N,ARMSTRONG D G,LIPSKY B A. Preventing foot ulcers in patients with diabetes[J]. JAMA,2005,293(2): 217-220.
[4] GEMECHU F W,SEEMANT F,CURLEY C A. Diabetic foot infections[J]. Am Fam Physician,2013,88(3): 177-181.
[5] COCKERILL F R. Performance standards for antimicrobial susceptibility testing, twenty-first informational supplement[M].USA: Clinical and Laboratory Standards Institute,2015.
[6] 柳迎昭,王丽,陈建国. 糖尿病足感染患者病原菌分布及耐药性分析[J]. 山西医药杂志,2014,43(19):2264-2266.
[7] 邓晓龙,肖立虎,陈大伟,等. 糖尿病足溃疡伴感染无菌棉拭子擦拭取样及深部组织活检取样细菌培养的一致性研究[J]. 中国糖尿病杂志,2014,4(7):504-508.
[8] 李慧琴,苏晓飞,丁波,等. 218 例糖尿病足患者临床特征及高危因素分析[J]. 中华内分泌代谢杂志,2012,28(6):492-495.
[9] 沈秋燕,林迪妮,朱虹,等.糖尿病足合并感染患者754株病原菌分布及耐药性分析[J]. 中华医学杂志,2014,94(12):889-894.
[10] 何杏仪,黄景胜,张莉. 糖尿病足合并感染患者病原菌分布及耐药性变迁[J]. 今日药学,2017,11(27):767-770.
[11] 王彬. 38 例糖尿病足感染患者病原菌特点及药敏回顾分析[J]. 糖尿病新世界,2015,(3):7-8.
[12] RAMAKANT P, VERMA A K, MISRA R, et al. Changing microbiological profile of pathogenic bacteria in diabetic foot infections: time for a rethink on which empirical therapy to choose? [J]. Diabetologia,2011,54(1): 58-64.
[13] 谢光云,吴世木,刘爽,等. 糖尿病足患者伤口感染的病原菌分布及药敏结果分析[J]. 中华医院感染学杂志,2017,17(27):3897-3990.

糖尿病足患者创面病原菌分布及耐药性变迁

Change of pathogen distribution and drug resistance in patients with diabetic foot

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 7

编辑推荐

Metrics

本文评价

[1]	郑素娟, 冯彩莲, 樊建凤. 高龄呼吸道感染患者病原菌检验以及耐药性监测结果分析[J]. 广州医药, 2021, 52(6): 83-86.
[2]	杜燕, 吴斌, 杨潇. 2016—2020年某院血流感染分离菌分布和耐药性分析[J]. 广州医药, 2021, 52(6): 90-96.
[3]	董云玲, 张风林, 李永兵, 郭瑞娟. 某院209株肺炎克雷伯菌临床分布和耐药性分析[J]. 广州医药, 2021, 52(4): 86-91.
[4]	王乐玲, 吴碧彤, 董海平, 林庆裕, 胡锦兴. 继发性肺结核合并肺部真菌感染的临床特点及危险因素分析[J]. 广州医药, 2021, 52(3): 79-83.
[5]	赵庚. 艾滋病继发真菌感染患者病情的临床特点与治疗措施分析[J]. 广州医药, 2021, 52(2): 37-39.
[6]	陈凤明, 肖小玲, 曾国庆, 苏怡. 微信式延续护理对真菌性外耳道炎患者心理及治疗效果的影响[J]. 广州医药, 2020, 51(4): 100-103.
[7]	马志平, 陈瑶. 2017—2018年汕头中心医院50例腹泻儿童鼠伤寒沙门菌临床分析[J]. 广州医药, 2020, 51(1): 66-69.